secwatch / observer
8-K filed June 11, 2026, 7:55 AM ET ticker RFL CIK 0001713863
earnings confidence high sentiment positive materiality 0.75

Rafael Holdings Q3 net loss $4.2M; Phase 3 NPC trial done, NDA submission H2 2026

Rafael Holdings, Inc.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Rafael Holdings, Inc. reported the fiscal quarter ended April 30, 2026 results: net income net loss attributable to Rafael Holdings of $4.2 million, or $0.08 per share, EPS $0.08 per share.

Period
the fiscal quarter ended April 30, 2026
Net income
net loss attributable to Rafael Holdings of $4.2 million, or $0.08 per share
EPS
$0.08 per share
Result
reported results
Exact text from the filing
For the three months ended April 30, 2026, we recorded a net loss attributable to Rafael Holdings of $4.2 million, or $0.08 per share, versus a net loss of $4.8 million, or $0.19 per share in the year ago period.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Rafael Holdings, Inc. reported the nine months ended April 30, 2026 results: net income net loss attributable to Rafael Holdings of $20.5 million, or $0.40 per share, EPS $0.40 per share.

Period
the nine months ended April 30, 2026
Net income
net loss attributable to Rafael Holdings of $20.5 million, or $0.40 per share
EPS
$0.40 per share
Result
reported results
Exact text from the filing
For the nine months ended April 30, 2026, we recorded a net loss attributable to Rafael Holdings of $20.5 million, or $0.40 per share, versus a net loss of $18.4 million, or $0.73 per share in the year ago period.
View on SEC.gov

309 earnings releases filed in the last 30 days. Browse all earnings releases →

Rafael Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-26-067555
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.